| |
| |
|
| Insider
Information: |
King Thomas Braxton |
| Relationship: |
President & CEO, Direc... |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
President & CEO, Direc... |
2016-06-21 |
0 |
2016-06-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEOOfficer |
• • – |
2006-03-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
181,817 |
|
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2006-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,070 |
1,055 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2007-03-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
275 |
181,542 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2007-08-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
435 |
168,607 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2007-12-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,500 |
153,607 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,822 |
56,190 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2010-12-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
69,070 |
185,177 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2010-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
69,070 |
11,190 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2011-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
91,135 |
102,325 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2011-05-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,962 |
102,325 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2011-05-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,962 |
187,139 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2012-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
65,516 |
167,841 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2012-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,116 |
9,113 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2012-08-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,116 |
20,482 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2013-02-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,113 |
0 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2013-02-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,113 |
30,149 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
President & CEO |
• • – |
2016-06-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(37,224) |
0 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
President & CEO |
• • – |
2016-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,000) |
0 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2013-07-26 |
4 |
B |
$4.49 |
$10,866 |
D/D |
2,420 |
215,000 |
2.81 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2009-12-17 |
4 |
AS |
$2.20 |
$17,368 |
D/D |
(7,892) |
98,709 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2009-12-17 |
4/A |
AS |
$2.20 |
$17,370 |
D/D |
(7,893) |
98,706 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2012-06-06 |
4 |
AS |
$0.34 |
$22,151 |
D/D |
(65,516) |
202,325 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2007-08-08 |
4 |
AS |
$9.25 |
$23,125 |
I/I |
(2,500) |
171,442 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2009-12-16 |
4 |
AS |
$2.41 |
$34,287 |
D/D |
(14,244) |
106,601 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Pres & CEO |
• • – |
2009-12-16 |
4/A |
AS |
$2.41 |
$34,292 |
D/D |
(14,246) |
106,599 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
